Drug-Drug Interaction Study of Pacritinib and CYP450,Transporter Substrates, and CYP450 3A4 in Healthy Male Subjects

NCT05657613 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Drug Interactions

Interventions

DRUG: CYP450 Cocktail and Transporter Substrates with Pacritinib
DRUG: Part 2 -Group A Bosentan 125 mg (CYP450 3A4 inducer) with Pacritinib
DRUG: Part 2 Group B - Fluconazole (CYP450 3A4 inhibitor) with Pacritinib

Sponsor

CTI BioPharma

Collaborators

[object Object]